Organic Chemistry TRIZ Cases

Terminal hydroxyl groups in perfluoropolyether lubricants bond to protective layers, reducing magnetic spacing while maintaining adhesion.

A sulfonium compound serves as a photoacid generator in chemically amplified resists to maintain high sensitivity during photolithography.

A specific compound forms the hole injection layer in organic electric elements to facilitate charge transport.

Masking groups shield kallikrein inhibitors from gastrointestinal metabolism, resolving the trade-off between injection efficacy and oral convenience.

A pyrene derivative with nitrogen-containing aromatic heterocyclic groups and alkyl or silyl substituents improves charge transport in organic electroluminescent elements.

Formic acid solvent drives thiazole ring formation, replacing toxic catalysts to boost yield.

Fluorenylporphyrin-anthracene copolymer enhances charge transfer and carrier transport properties in organic photovoltaic devices.

A phenoxyphenol compound with bulky alkyl groups suppresses thermal degradation in organic materials.

Optimizing the mixing ratio of methionine to carrier gas suppresses particle crushing and prevents pipe clogging during pneumatic conveyance.

Organic dyes use diphenylamine donors and CN-COOZ acceptors to enhance photoelectric conversion efficiency.

Dynamic disulfide bond rearrangement in the epoxy matrix repairs structural damage during Joule heating, maintaining dimensional stability at high temperatures.

A resist underlayer film composition forms flat, heat-resistant layers using specific aromatic polymers.

An auxiliary capping layer reduces optical energy loss from surface plasmon polaritons in organic electric elements, boosting luminous efficiency and lifetime.

Specific aromatic aldehyde and amine structures prevent gelation during processing, enabling large-scale industrial applications.

Modifying phenanthroline structure raises glass transition temperature above 100 C, resolving device instability caused by low thermal limits in OLED panels.

Process converts unstable hexose intermediates into stable FDCA esters by extracting corrosive conditions through biphasic transesterification.

A mixed solvent system enables efficient salt-forming reaction and crystallization of lurasidone hydrochloride.

Aryl-substituted imidazoles inhibit MDM2 and MDMX to restore p53 activity, overcoming the limitation of single-target inhibitors in cancer therapy.

N-alkoxyacyl hydrazine cyclization yields oxadiazacyclic compounds without expensive protective groups.

A tertiary alkoxide base lowers reaction mixture viscosity during triazine carbamate preparation.

Formula I compounds reduce renal interstitial macrophages and increase podocyte numbers to treat focal segmental glomerulosclerosis.

Replacing tin dichloride with vitamin C derivatives eliminates environmental toxicity while maintaining high yield in indazole synthesis.

Selective extraction of ketose intermediates prevents sugar loss to side-reactions, enabling high-yield furan production at mild temperatures.

Modified oxime ester structures increase photoabsorption at 365 nm and 405 nm, resolving low sensitivity in short-wavelength photopolymerization.

1,2,4-Triazine derivatives modulate TLR7 and TLR8 to improve therapeutic efficacy while maintaining metabolic stability.

Branched cationic lipids shield nucleic acids from plasma nuclease digestion while enabling intracellular release.

Thiadiazolin-3,5-dione compounds treat existing HPV infections by disrupting E6-p53 interactions.

Condensed three-ring and four-ring hetero compounds lower driving voltage while improving emission efficiency and device life.

Replacing traditional reagents with N-bromosuccinimide reduces waste and cost while maintaining synthesis efficiency for the target pyrazole compound.

Acoustic cavitation accelerates intramolecular Friedel-Crafts cyclization of ortho-acetal diarylmethanols to polycyclic aromatic hydrocarbons.

Modulating serotonin, dopamine, and noradrenaline ratios via structural parameter changes resolves activity balance contradictions.

Nitrogen-containing modifiers broaden molecular weight distribution and increase molecular weight while maintaining high productivity.

Formula I compounds overcome partial agonist limitations by delivering superior receptor activation and selectivity against dopamine D2 receptors.

Ester compounds derived from neo-acids replace polyalpha-olefins in lubricating oil compositions to resolve low polarity and poor oxidation stability.

Oxidative dearomatization creates berbine derivatives with cyclohexadienone moieties, improving therapeutic efficacy despite increased reaction complexity.

Sulfonium salt quencher suppresses acid diffusion in resist compositions to improve line width roughness and critical dimension uniformity.

A metal-free polyamine-boron reaction product acts as a detergent in marine engine oils.

A quinoxaline derivative bonded to an anthracene skeleton enhances electron transport in organic light-emitting devices.

A one-pot synthesis process converts naltrexone and hydrazine into norBNI using methanesulfonic acid catalysis in polar solvents.

Small molecule antagonists block CGRP receptor activation to alleviate migraines while avoiding cardiovascular liabilities of triptans.

Modified phebox ligands enable alkane dehydrogenation under milder conditions, resolving catalyst stability trade-offs.

Replacing esterase bonds with reactive oxygen species-cleavable links enables targeted prodrug activation at disease sites while reducing systemic side effects.

Targeting ligand degrader compounds recruit E3 ligases to degrade PTPN2 and PTPN1 proteins via the ubiquitin-proteasome pathway.

Specific organic amine structure reduces metal corrosion while ensuring complete photoresist removal in spray processes.

Azabicyclohexane derivatives target dopamine D3 receptors to treat drug dependency while reducing extrapyramidal side effects.